Plasmids are critical for the production of traditional biologics and gene therapies, enabling the programming of cells to perform work that these cells were not originally designed to complete. There can be single plasmid stable transfections for biologics, while gene therapies may use up to three plasmids for a triple transient transfection process to produce viral vectors. Plasmids are commonly generated using microbial cell lines. Escherichia coli (E. coli) is the industry leader for plasmid production, however, there are other alternatives that can be used.

Download the Document

* denotes a required field

Please fill out the information below. If you are already registered, login and this information will be filled out for you.

Name *
Please enter your first and last name.
Company/Institution *
Please enter the name of the company or institution you work at.
Address *
Please enter your mailing address.
Email Address *
Please enter the e-mail address you would like to be contacted at.
Work Phone Number *
Please enter the phone number you would like to be contacted at.

By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.

Plasmid GMP Testing

Oops! It looks like there were some errors.

Download the Document